Wolfgang Lechner

Wolfgang Lechner

Auto-generated profile, based on publicly available information

Wolfgang Lechner

Medical University of Vienna, Department of Radiation Oncology, Vienna, Austria

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2014 in Medical Physics
Verified
Journal Article
Closed access
GAGodfrey Azangwe
Godfrey Azangwe
PGPaulina Grochowska
Paulina Grochowska
Dietmar GeorgDietmar Georg
Dietmar Georg
JIJoanna Izewska
Joanna Izewska
JHJohannes Hopfgartner
Johannes Hopfgartner
HPHugo Palmans
Hugo Palmans

13 December 2023 in Physics in Medicine & Biology
Verified
Journal Article
Open access
LNLena Nenoff
Lena Nenoff
FAFlorian Amstutz
Florian Amstutz
MMMartina Murr
Martina Murr
BABen Archibald-Heeren
Ben Archibald-Heeren
MFMarco Fusella
Marco Fusella
EOEliana Vasquez Osorio
Eliana Vasquez Osorio
Deformable image registration (DIR) is a versatile tool used in many applications in radiotherapy (RT). DIR algorithms have been implemented in many commercial treatment planning systems providing accessible and easy-to-use solutions. However, the geometric uncertainty of DIR can be large and difficult to quantify, resulting in barriers to clinical practice. Currently, there is no agreement in the RT community on how to quantify these uncertainties and determine thresholds that distinguish a good DIR result from a poor one. This review summarises the current literature on sources of DIR uncertainties and their impact on RT applications. Recommendations are provided on how to handle these uncertainties for patient-specific use, commissioning, and research. Recommendations are also provided for developers and vendors to help users to understand DIR uncertainties and make the application of DIR in RT safer and more reliable.

1 March 2018 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
PDF file
SKSuphalak Khachonkham
Suphalak Khachonkham
RDRalf Dreindl
Ralf Dreindl
Gerd HeilemannGerd Heilemann
Gerd Heilemann
WLWolfgang Lechner
Wolfgang Lechner
HFHermann Fuchs
Hermann Fuchs
PKPeter Kuess
Peter Kuess
Recently, a new type of radiochromic film, the EBT-XD film, has been introduced for high dose radiotherapy. The EBT-XD film contains the same structure as the EBT3 film but has a slightly different composition and a thinner active layer. This study benchmarks the EBT-XD against EBT3 film for 6 MV and 10 MV photon beams, as well as for 97.4 MeV and 148.2 MeV proton beams and 15–100 kV x-rays. Dosimetric and film reading characteristics, such as post irradiation darkening, film orientation effect, lateral response artifact (LRA), film sensitivity, energy and beam quality dependency were investigated. Furthermore, quenching effects in the Bragg peak were investigated for a single proton beam energy for both film types, in addition measurements were performed in a spread-out Bragg peak. EBT-XD films showed the same characteristic on film darkening as EBT3. The effects between portrait and landscape orientation were reduced by 3.1% (in pixel value) for EBT-XD compared to EBT3 at a dose of 2000 cGy. The LRA is reduced for EBT-XD films for all investigated dose ranges. The sensitivity of EBT-XD films is superior to EBT3 for doses higher than 500 cGy. In addition, EBT-XD showed a similar dosimetric response for photon and proton irradiation with low energy and beam quality dependency. A quenching effect of 10% was found for both film types. The slight decrease in the thickness of the active layer and different composition configuration of EBT-XD resulted in a reduced film orientation effect and LRA, as well as a sensitivity increase in high-dose regions for both photon and proton beams. Overall, the EBT-XD film improved regarding film reading characteristics and showed advantages in the high-dose region for photon and proton beams.

20 November 2013 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
PDF file
WLWolfgang Lechner
Wolfgang Lechner
HPHugo Palmans
Hugo Palmans
LSLukas Sölkner
Lukas Sölkner
PGPaulina Grochowska
Paulina Grochowska
Dietmar GeorgDietmar Georg
Dietmar Georg

1 January 2018 in Physics and Imaging in Radiation Oncology
Verified
Journal Article
Open access
WLWolfgang Lechner
Wolfgang Lechner
PWPaulina Wesolowska
Paulina Wesolowska
GAGodfrey Azangwe
Godfrey Azangwe
MAMehenna Arib
Mehenna Arib
VAVictor Gabriel Leandro Alves
Victor Gabriel Leandro Alves
JIJoanna Izewska
Joanna Izewska
An audit methodology for verifying the implementation of output factors (OFs) of small fields in treatment planning systems (TPSs) used in radiotherapy was developed and tested through a multinational research group and performed on a national level in five different countries. Centres participating in this study were asked to provide OFs calculated by their TPSs for 10 × 10 cm2, 6 × 6 cm2, 4 × 4 cm2, 3 × 3 cm2 and 2 × 2 cm2 field sizes using an SSD of 100 cm. The ratio of these calculated OFs to reference OFs was analysed. The action limit was ±3% for the 2 × 2 cm2 field and ±2% for all other fields. OFs for more than 200 different beams were collected in total. On average, the OFs for small fields calculated by TPSs were generally larger than measured reference data. These deviations increased with decreasing field size. On a national level, 30% and 31% of the calculated OFs of the 2 × 2 cm2 field exceeded the action limit of 3% for nominal beam energies of 6 MV and for nominal beam energies higher than 6 MV, respectively. Modern TPS beam models generally overestimate the OFs for small fields. The verification of calculated small field OFs is a vital step and should be included when commissioning a TPS. The methodology outlined in this study can be used to identify potential discrepancies in clinical beam models.

1 December 2013 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
WLWolfgang Lechner
Wolfgang Lechner
GKGabriele Kragl
Gabriele Kragl
Dietmar GeorgDietmar Georg
Dietmar Georg